U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07332936) titled 'Tobradex as Intracanal Medicament' on Dec. 30, 2025.
Brief Summary: The goal of this prospective clinical study was to evaluate and compare the short-term effects of two intracanal medicaments-calcium hydroxide and a tobramycin-dexamethasone combination (Tobradex)-on postoperative pain following emergency root canal treatment in adult patients with symptomatic irreversible pulpitis.
The main question it aimed to answer was:
Does Tobradex reduce postoperative endodontic pain more effectively than calcium hydroxide within the first 48 hours after emergency root canal treatment? Adult patients presenting with acute dental pain and al...